UK Markets closed

Titan Medical Inc. (TMDI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.6500-0.0500 (-2.94%)
At close: 4:00PM EDT
1.6700 +0.02 (+1.21%)
After hours: 04:36PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.7000
Open1.7000
Bid1.6500 x 1200
Ask1.6700 x 1100
Day's range1.6500 - 1.7100
52-week range0.6500 - 3.4700
Volume175,264
Avg. volume396,338
Market cap180.721M
Beta (5Y monthly)4.65
PE ratio (TTM)N/A
EPS (TTM)-0.4760
Earnings date15 Nov 2021 - 19 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Titan Medical Announces Completion of Pre-Clinical GLP Studies

    TORONTO, October 25, 2021--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced today that it has completed its scheduled pre-clinical studies with its Enos™ robotic single access surgical system, performed in accordance with FDA’s good laboratory practice (GLP) regulations. GLP is a set of principles intended to assure the quality and integrity of non-clinical laboratory

  • Business Wire

    Titan Medical to Participate in Upcoming Investor Conferences in September

    TORONTO, September 14, 2021--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of its innovative surgical technologies for robotic single access surgery, today announced that David McNally, President and CEO of Titan Medical, will present an overview of the company and its Enos™ robotic single access surgical system and participate in one-on-one investor meetings at two upcoming investor conferences:

  • Business Wire

    Titan Medical to Participate in H.C. Wainwright Investor Conference

    TORONTO, September 07, 2021--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of its innovative surgical technologies for robotic single access surgery, today announced that David McNally, President and CEO of Titan Medical, will present an overview of the company and its Enos™ robotic single access surgical system at the H.C. Wainwright 23rd Annual Global Investment Conference on Monday, September 13, 2021. The presentation w